Active
- UCSD IRB#190972—UCSD Newborn Screening for Autism Risk using Dried Blood Spots—Phase 2
- UCSD IRB#140072—Metabolomic Studies of Complex Chronic Disease
Completed
- UCSD IRB#171940— UCSD Newborn Screening for Autism Risk using Dried Blood Spots—Phase 1 Completed
- UCSD IRB#150134—The Suramin Autism Treatment 1 (SAT1) Trial—Completed.
Basic Science and Translational Studies
- Metabolomics of the immune response in ASD—regulating the cell danger response (CDR)
- Metabolomic similarities between Lyme Disease and ME/CFS—characterizing the CDR in males and females
- Characterizing the Exposome of ME/CFS and Lyme Disease
- Metabolic features to predict the risk of recurrent major depression
- Metabolic features of major depressive disorder with suicidal ideation
- Generational Transmission of the Exposome using Dried Blood Spots—1980-2020
- Metabolomics of Primary Mitochondrial Disease—MELAS, NARP, Kearns-Sayre
- Metabolomics of exercise and aging
- Metabolomics of breast milk at 2-4 months to predict the risk of autism
- C. elegans dauer entry and exit metabolomics
- Metabolomics of iHHV-6 reactivation in ME/CFS
- Metabolomics of hyperpurinergia in mice